Minted: - / 5000

900 Remoxipride
8d40937fda25b0257cacdffc182b1c1c46977d35a5fdfc9853d1ca056c05db84

Properties

Background

Red
Bottle

Light green
Cap

Gray
Syringe

Purple
Bubbles
No
Drops
No
Label
Bacterium

Chemistry

Formula
C16H23BrN2O3
Carbon
16
Polarity
Neutral

Remoxipride (Roxiam) is an atypical antipsychotic (although according to some sources it is a typical antipsychotic) which was previously used in Europe for the treatment of schizophrenia and acute mania but was withdrawn due to toxicity concerns (incidence of aplastic anemia in 1/10,000 patients). It was initially launched by AstraZeneca in 1990 and suspension of its use began in 1993. Remoxipride acts as a selective D₂ and D₃ receptor antagonist and also has high affinity for the sigma receptor, possibly playing a role in its atypical neuroleptic action.

From Wikipedia, the free encyclopedia. License: CC BY-SA.